Timber Pharmaceuticals Inc (NYSE MKT LLC:TMBR)

Expected performance: Start your 30-days free trial
About the company

Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases. The Company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. The Company is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), facial angiofibromas (FAs) in tuberous sclerosis complex (TSC), and scleroderma.

Exchange

NYSE MKT LLC

Website

www.timberpharma.com

$NoneM

Total Revenue

6

Employees

$15.68M

Market Capitalization

-1.01

Price/Earning ratio

Stock price

Gross Margin (%)

Total gross margin

Operating Margin (%)

Total operating margin

Net Margin (%)

Total net margin

Dividend Yield (%)

Dividend per share

$0

90-days Stock Price Forecast (%)

PREDICT MONTHLY

$29.9 / Month

  • 4000+ Daily forecasts
  • Company fundamentals
  • Follow list
  • Industry leaderboard
  • Portfolio optimization
  • Billed monthly
  • Cancel anytime

OPTIMIZE YEARLY

$479.9 / Year

  • 4000+ Daily forecasts
  • Company fundamentals
  • Follow list
  • Industry leaderboard
  • Portfolio optimization
  • Billed yearly
  • Cancel anytime

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (%)
Conversion Labs Inc CVLB 108548.37 35213.00 3.74 42.66 7.33
Royalty Pharma plc RPRX 23187.40 2195.00 4.75 43.41 24.23
Organon & Co. OGN 7339.53 7822.00 1.56 3.96 23.73
Arvinas Inc ARVN 4246.20 21.00 8.07 -30.64 -656.62
Cronos Group Inc CRON 2616.35 51.00 1.74 -8.47 -610.02
ATAI Life Sciences N.V. ATAI 2371.50 20.00 21.23 -12.81 -932.88
Tilray Inc TLRY 2144.52 210.00 8.18 -7.92 -128.79
Usana Health Sciences Inc USNA 2000.67 1176.00 4.79 15.67 10.95
Phathom Pharmaceuticals Inc PHAT 1091.40 None 6.11 -7.61 None
Phibro Animal Health Corp. PAHC 970.47 799.00 4.44 22.33 5.37
Edgewise Therapeutics Inc EWTX 857.99 None 2.82 -41.69 None
Intersect ENT Inc XENT 770.55 85.00 14.78 -10.20 -87.96
Pliant Therapeutics Inc PLRX 727.20 15.00 2.74 -11.22 -427.75
Chromadex Corp CDXC 538.78 60.00 13.37 -24.83 -35.92
Urovant Sciences Ltd UROV 503.44 None -3.65 -3.08 None
Rain Therapeutics Inc RAIN 432.90 None -10.03 -17.16 None
Evolus Inc EOLS 389.52 58.00 25.16 -2.65 -234.84
Cyteir Therapeutics Inc CYT 365.75 None -12.18 -17.04 None
Ikena Oncology Inc IKNA 356.76 9.00 1.56 -7.56 -498.11
Provention Bio Inc PRVB 339.92 None 2.09 -2.84 None
Verrica Pharmaceuticals Inc VRCA 267.50 12.00 4.73 -7.87 -281.73
LifeMD Inc LFMD 255.06 51.00 -31.65 -2.09 -141.77
Adicet Bio Inc ACET 236.80 12.00 1.00 -4.40 -448.84
Osmotica Pharmaceuticals Plc OSMT 206.46 153.00 2.45 -2.36 -56.24
Fulcrum Therapeutics Inc FULC 204.68 13.00 1.87 -2.90 -539.31
Kala Pharmaceuticals Inc KALA 200.10 9.00 2.03 -1.78 None
Kaleido Biosciences Inc KLDO 195.48 1.00 3.21 -2.28 None
Milestone Pharmaceuticals Inc MIST 193.80 None 1.29 -4.29 None
Terns Pharmaceuticals Inc TERN 187.50 None 0.99 -5.56 None
Longboard Pharmaceuticals Inc LBPH 153.00 None 1.29 -7.50 None
scPharmaceuticals Inc SCPH 142.48 119.00 1.99 -4.49 -27.05
Eton Pharmaceuticals Inc ETON 118.22 12.00 5.84 -8.03 -116.63
Odonate Therapeutics Inc ODT 116.90 None 1.22 -0.89 None
Citius Pharmaceuticals Inc CTXR 115.29 None 2.20 -5.73 None
VYNE Therapeutics Inc VYNE 113.40 23.00 1.49 -0.60 -483.51
Aquestive Therapeutics Inc AQST 110.50 48.00 -2.29 -2.06 -111.86
Natural Alternatives International, Inc. NAII 106.26 169.00 1.50 11.97 5.68
Eyenovia Inc EYEN 97.29 4.00 9.00 -5.04 -491.77
Aerpio Pharmaceuticals Inc ARPO 88.88 15.00 2.46 -22.44 -32.26
India Globalization Capital Inc IGC 74.34 1.00 2.60 -8.43 -981.18
Opiant Pharmaceuticals Inc OPNT 64.48 32.00 2.05 -23.03 -9.52
Acasti Pharma Inc ACST 54.74 0.00 1.70 -2.71 -611.47
Mannatech Inc MTEX 52.62 153.00 2.06 9.89 3.70
Assertio Holdings Inc ASRT 39.06 112.00 0.52 -0.42 -57.78
Trevi Therapeutics Inc TRVI 34.20 None 1.73 -1.08 None
Bio-Path Holdings Inc BPTH 25.60 0.00 1.42 -2.71 18.96
Lexaria Bioscience Corp LEXX 24.92 1.00 3.07 -6.36 -445.15
Baudax Bio Inc BXRX 20.13 1.00 -61.00 -3.59 None
Nabriva Therapeutics Plc NBRV 18.70 5.00 0.99 -0.32 None
Cyanotech Corp. CYAN 18.36 32.00 1.10 20.40 2.84
Hoth Therapeutics Inc HOTH 18.06 None 1.54 -2.02 None
Reviva Pharmaceuticals Holdings Inc. RVPH 17.50 None 13.46 -3.27 None
Timber Pharmaceuticals Inc TMBR 15.68 None 6.13 -1.01 None
Sonoma Pharmaceuticals Inc. SNOA 13.42 19.00 2.62 -3.41 -21.20
Shineco Inc TYHT 11.88 14.00 0.61 -0.58 -159.60

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Investing Now Could Prove Beneficial For Timber Pharmaceuticals Inc. (AMEX: TMBR)

7d ago, source: marketingsentinel

During the last session, Timber Pharmaceuticals Inc. (AMEX:TMBR)’s traded shares were 0.52 million, with the beta value of ...

Timber Pharmaceuticals Inc. (AMEX: TMBR): A Disaster In The Making Or A Gold Mine?

11d ago, source: marketingsentinel

In the last trading session, 1.34 million shares of the Timber Pharmaceuticals Inc. (AMEX:TMBR) were traded, and its beta was 0.30. Most recently the company’s share price was $0.96, and it changed ...

CatchMark's Triple T Joint Venture Reaches Definitive Agreement on Sale of 301,000 Acres of Prime East Texas Timberlands

1d ago, source: Le Lézard

CatchMark Timber Trust, Inc. today announced its Triple T joint venture has reached a definitive agreement with a client of the Hancock Natural Resource Group, Inc., a Manulife Investment Management ...

Early Warning Press Release

3d ago, source: Yahoo Finance

Swets, Timber Country Investment Corporation (Timber Country) and Rivett Capital Syndicate Inc. (Rivett Capital and, together with Larry G. Swets and Timber Country, the Acquirors) transferred rights ...

Interim Report Q2 2021: SCA

8d ago, source: PR Newswire

The supply of wood to SCA's industries was stable throughout the quarter. Prices for timber and pulpwood were stable compared with the preceding period. The market situation for solid-wood ...

Shutdowns, sales and uncertainty: Can Wisconsin's paper industry adapt to remain viable post-COVID?

12d ago, source: Wisconsin Rapids Daily Tribune

Nor is it clear how it affects the work of a task force of local and state officials and a cooperative created by timber companies ... In July, Neenah Inc. announced it would close its paper ...

Rayonier Sells Two Timber Funds to BTG Pactual’s Timberland Investment Group

9d ago, source: Yahoo Finance

WILDLIGHT, Fla., July 22, 2021--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) has sold the rights to manage two timber funds (Fund III and Fund IV) that were previously managed by its Olympic Resource ...

Your Portfolio

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.